1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "1787294-07-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-128757
    Remibrutinib

    Btk Inflammation/Immunology
    Remibrutinib, is a potent and orally active bruton tyrosine kinase (BTK) inhibitor with an IC50 value of 1 nM. Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib has the potential for Chronic urticaria (CU) treatment.